surmount-1 tirzepatide trial obesity without diabetes SURMOUNT-1: Adults achieve weight loss of 16% or more at 72 weeks with surmount-1 tirzepatide non-diabetic obesity trial
Pay in 4 interest-free payments of $6.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26


























